No headlines found.
Cannabis Market Flourishes Amid Global Legalization, Driving Concerns About Road Safety
Globe Newswire (Mon, 22-Apr 9:30 AM ET)
International Star Inc. Appoints Todd Masse as New CEO
ACCESSWIRE (Wed, 10-Apr 10:12 AM ET)
Aurora Cannabis Commends Germany's Landmark Legalization Achievement
PRNewswire (Mon, 1-Apr 7:00 AM ET)
PRNewswire (Wed, 20-Mar 7:15 AM ET)
Aurora Introduces Medical Cannabis Pastilles for Patient Relief in Australia
PRNewswire (Mon, 4-Mar 9:42 AM ET)
PRNewswire (Thu, 29-Feb 5:00 PM ET)
Aurora Partners with Script Assist to Provide Better Access to UK Medical Cannabis
PRNewswire (Wed, 28-Feb 7:11 AM ET)
Aurora Cannabis Announces CFO Transition and Completion of Previously Announced Share Consolidation
PRNewswire (Tue, 20-Feb 7:00 AM ET)
PRNewswire (Thu, 8-Feb 7:00 AM ET)
Aurora Cannabis Acquires MedReleaf Australia
PRNewswire (Thu, 8-Feb 6:45 AM ET)
Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements.
Aurora Cannabis - Common Shares trades on the NASDAQ stock market under the symbol ACB.
As of April 25, 2024, ACB stock price declined to $6.79 with 1,886,002 million shares trading.
ACB has a beta of 1.16, meaning it tends to be more sensitive to market movements. ACB has a correlation of 0.02 to the broad based SPY ETF.
ACB has a market cap of $370.32 million. This is considered a Small Cap stock.
Last quarter Aurora Cannabis - Common Shares reported $47 million in Revenue and -$.40 earnings per share. This beat revenue expectation by $481,000 and missed earnings estimates by -$.30.
In the last 3 years, ACB stock traded as high as $106.40 and as low as $2.84.
The top ETF exchange traded funds that ACB belongs to (by Net Assets): MJ.
ACB stock has underperformed the market in the last year with a return of +13.7%, while SPY returned +22.7%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in ACB shares. However, ACB has outperformed the market in the last 3 month and 2 week periods, returning +75.9% and +0.4%, while SPY returned +3.2% and -2.9%, respectively. This indicates ACB has been having a stronger performance recently.
ACB support price is $6.49 and resistance is $7.91 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ACB stock will trade within this expected range on the day.